2018
DOI: 10.2147/cmar.s165291
|View full text |Cite
|
Sign up to set email alerts
|

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study

Abstract: BackgroundCarcinoma of the axillary tail of Spence (CATS) is a poorly studied type of breast cancer. The clinicopathological characteristics and prognostic features of CATS are unclear.MethodsUsing the Surveillance, Epidemiology, and End Results database, we identified 149,026 patients diagnosed with upper outer quadrant breast cancer (UOBC) (n=146,343) or CATS (n=2,683). The median follow-up was 88 months. The primary and secondary outcomes were breast cancer-specific survival (BCSS) and overall survival. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 21 publications
0
4
0
2
Order By: Relevance
“…In the present study, however, there was no significant difference in the number of tumors evaluated as T1 and T2/T3 in LN-positive and -negative groups ( p = 0.340), which was similar to the results of the previous study; that is, tumor size on ultrasound was not an independent predictor of axillary LN metastasis ( 28 ). Breast tumor location has been acknowledged as an independent factor of tumor prognosis, and malignant tumors in the lower inner quadrant were related to a worse prognosis because of the internal mammary lymphatic pathway without sufficient studies ( 32 ). However, there was no significant difference in tumor location ( p = 0.390) in LN-positive and -negative groups in our study.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, however, there was no significant difference in the number of tumors evaluated as T1 and T2/T3 in LN-positive and -negative groups ( p = 0.340), which was similar to the results of the previous study; that is, tumor size on ultrasound was not an independent predictor of axillary LN metastasis ( 28 ). Breast tumor location has been acknowledged as an independent factor of tumor prognosis, and malignant tumors in the lower inner quadrant were related to a worse prognosis because of the internal mammary lymphatic pathway without sufficient studies ( 32 ). However, there was no significant difference in tumor location ( p = 0.390) in LN-positive and -negative groups in our study.…”
Section: Discussionmentioning
confidence: 99%
“…We derived a dataset of female breast cancer patients diagnosed from 2010 to 2013, for the reason of known HER2 status and follow-up time. The inclusion criteria were as follows: females aged over 18 years old; American Joint Committee on Cancer stages (the seventh AJCC System) TNM stage I–III;21,22 unilateral breast cancer; breast cancer as the first and only cancer diagnosis; TCNP or tumor in the breast peripheral quadrant (TBPQ) (including UOQ, UIQ, lower outer quadrant, LIQ, but overlapping sites were excepted); diagnosis not obtained from a death certificate or autopsy; pathologic confirmation of breast cancer; known tumor differentiation status (histological score);2325 known HR and HER2 status;2628 known tumor size and LN status; known surgery type; known radiation/chemotherapy; and active follow-up. Patients with incomplete information were excluded.…”
Section: Methodsmentioning
confidence: 99%
“…It is usually detected in the early stages and is characterized by a lack of hormone receptors [ 4 , 7 , 8 ]. Compared to upper outer quadrant (UOQ) breast cancer, CATS has a higher grade, a higher rate of negative hormone receptors, and a greater tendency to spread to the lymph nodes, leading to a poorer prognosis [ 9 ]. In our case, a 46-year-old woman presented with advanced stage of CATS with bleeding and ulceration.…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis for CATS depends on the stage when diagnosed. Compared to UOQ breast cancer, CATS has a lower 10-year breast cancer-specific survival (BCSS) rate, particularly in the metastatic lymph node and hormone receptor-negative subgroups [ 9 ]. The estimated five-year disease-free survival rate for CATS is 67 %.…”
Section: Discussionmentioning
confidence: 99%